Q1 2019 Holdings
Filed 2019-05-15 | 164 holdings | $184.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | ADR | 04351P101 | $117.5M | 998,538 | 63.6% |
| Coherus BioSciences(CHRS) | COMM | 19249H103 | $39.1M | 2,868,221 | 21.2% |
| Aclaris Therapeutics(ACRS) | COMM | 00461U105 | $11.5M | 1,911,573 | 6.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COMM | 02043Q107 | $10.0M | 106,616 | 5.4% |
| Akebia Therapeutics Inc(AKBA) | COMM | 00972D105 | $4.2M | 516,761 | 2.3% |
| Biomarin Pharmaceutical Inc(BMRN) | COMM | 09061G101 | $1.6M | 18,494 | 0.9% |
| Amarin | ADR | 023111206 | $108.1K | 5,208,305 | 0.1% |
| Principia Biopharma(PRNB) | COMM | 74257L108 | $69.3K | 2,038,208 | 0.0% |
| Natera(NTRA) | COMM | 632307104 | $63.9K | 3,100,560 | 0.0% |
| ObsEva SA | COMM | H5861P103 | $60.7K | 4,749,623 | 0.0% |
| Y-mAbs Therapeutics, Inc(YMABUSD) | COMM | 984241109 | $55.2K | 2,104,278 | 0.0% |
| Spark Therapeutics | COMM | 84652J103 | $54.8K | 481,270 | 0.0% |
| Nucana Biomed Ltd | Ordinary Shares | GB00BYWYV | $40.8K | 2,400,000 | 0.0% |
| Nucana Biomed Ltd | ADR | 67022C106 | $38.5K | 2,266,666 | 0.0% |
| Audentes Therapeutics(BOLDEUR) | COMM | 05070R104 | $36.4K | 933,640 | 0.0% |
| Merus N.V. | COMM | N5749R100 | $29.0K | 1,961,039 | 0.0% |
| Ishares Nasdaq BiotechnologyPut | COMM | 464287956 | $27.1K | 242,000 | 0.0% |
| Kiniksa Pharmaceuticals, Ltd | COMM CL A | G5269C101 | $16.7K | 922,700 | 0.0% |
| Iterum Therapeutics | COMM | G6333L101 | $13.7K | 1,726,514 | 0.0% |
| Allergan plc | COMM | G0177J108 | $13.0K | 88,665 | 0.0% |
| Novo Nordisk A/S(NVO) | ADR | 670100205 | $13.0K | 247,734 | 0.0% |
| AbbVie Inc(ABBV)Call | COMM | 00287Y109 | $12.1K | 150,000 | 0.0% |
| AstraZeneca PLC(AZN) | ADR | 046353108 | $10.6K | 261,577 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COMM | 64125C109 | $9.9K | 112,406 | 0.0% |
| Biogen Inc(BIIB)Call | COMM | 09062X103 | $9.5K | 40,000 | 0.0% |
| MacroGenics Inc(MGNX) | COMM | 556099109 | $9.4K | 523,756 | 0.0% |
| Chiasma(CHMA) | COMM | 16706W102 | $8.5K | 1,630,221 | 0.0% |
| Entasis Therapeutics Holdings Inc. | COMM | 293614103 | $8.0K | 1,180,178 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COMM | 03152W109 | $7.9K | 584,108 | 0.0% |
| AnaptysBio Inc(ANAB) | COMM | 032724106 | $7.2K | 97,948 | 0.0% |
| Dermira Inc(DERMEUR) | COMM | 24983L104 | $6.6K | 483,640 | 0.0% |
| Xencor Inc(XNCR) | COMM | 98401F105 | $6.5K | 209,907 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COMM | 40637H109 | $6.5K | 401,329 | 0.0% |
| Biohaven Pharmaceutical Holding Company Ltd(BHVN) | COMM | G11196105 | $6.4K | 124,952 | 0.0% |
| MorphoSys AG | COMM | D55040105 | $6.3K | 69,344 | 0.0% |
| Blueprint Medicines Corp(2L9) | COMM | 09627Y109 | $5.8K | 71,866 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COMM | 427746102 | $5.7K | 233,651 | 0.0% |
| Savara Inc(SVRA) | COMM | 805111101 | $5.7K | 766,672 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | COMM | 75615P103 | $5.6K | 65,031 | 0.0% |
| Intercept Pharmaceuticals Inc(ICPTUSD) | COMM | 45845P108 | $5.0K | 44,918 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | COMM | 24344T101 | $5.0K | 214,604 | 0.0% |
| Orchard Therapeutics PLC | ADR | 68570P101 | $4.9K | 276,083 | 0.0% |
| Incyte Corp(INCY) | COMM | 45337C102 | $4.6K | 53,097 | 0.0% |
| Kadmon Holdings Inc(KDMN) | COMM | 48283N106 | $4.4K | 1,671,770 | 0.0% |
| Synlogic Inc. | COMM | 87166L100 | $4.4K | 574,972 | 0.0% |
| Insmed Inc(INSM) | COMM | 457669307 | $4.1K | 140,057 | 0.0% |
| Puma Biotechnology Inc(PBYI)Call | COMM | 74587V107 | $3.6K | 93,800 | 0.0% |
| Fate Therapeutics Inc(FATE) | COMM | 31189P102 | $3.6K | 203,742 | 0.0% |
| GW Pharmaceuticals PLC | ADR | 36197T103 | $3.4K | 20,000 | 0.0% |
| FibroGen Inc(FGENEUR) | COMM | 31572Q808 | $3.2K | 59,017 | 0.0% |